Introduction: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy
INTRODUCTION
Peritoneal carcinomatosis (PC) was previously a lethal condition with dismal survival rate.
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have been described as the treatment of choice for selected patients with evidence of PC from the gastrointestinal tract, peritoneum, ovaries and the disease of pseudomyxoma peritonei.
(1-3) CRS aims to remove macroscopic disease while HIPEC works synergistically by removing microscopic tumour load at 42°-43°C. HIPEC achieves high peritoneal concentrations of chemotherapy but limited systemic absorption. (4) The combination of CRS and HIPEC is a complex procedure with many anaesthetic considerations. There is scant evidence in the literature regarding the anaesthetic management of patients undergoing CRS and HIPEC. In this review, we give a brief overview of CRS and HIPEC as well as share our anaesthetic outcomes. Due to the general paucity of evidence, unless otherwise referenced, recommendations in this article are based on the authors' experience.
The National Cancer Centre Singapore is a tertiary cancer centre with the largest published experience in CRS and HIPEC for colorectal, ovarian, appendiceal and primary peritoneal cancers in Asia. This paper aims to review all CRS and HIPEC procedures performed at our centre between January 1997 and December 2012, with a focus on perioperative events and anaesthetic implications.
METHODS
After receiving approval from the centralised institutional review board of the Singapore Health Services, all patients who had undergone CRS and HIPEC at the National Cancer Centre
Singapore were included in this study. A total of 111 consecutive patients who had undergone 113 CRS and HIPEC procedures until December 2012 were analysed. Anaesthetic and perioperative data were collected from patients' medical records and the National Cancer
Center prospective database. The medical records of patients with complications were reviewed in greater detail.
Patients with PC were considered for CRS and HIPEC if they had appropriate primary tumour histology, were medically fit with an Eastern Cooperative Group (ECOG) performance status 0 or 1, and without distant metastases. The extent of disease, feasibility of adequate cytoreduction and tumour clearance were examined on computed tomography (CT) or positron emission tomography (PET)-CT and discussed at the multidisciplinary tumour board meetings to determine patients' suitability.
All patients were admitted the day before surgery and reviewed. Baseline full blood counts, renal panel, coagulation profile, blood-group crossmatch, electrocardiography and chest radiography were performed. Patients were given 2 L of polyethylene glycol for bowel preparation and subcutaneous enoxaparin for deep vein thrombosis prophylaxis.
Anaesthetic management was selected by the anaesthetist in charge. All patients were managed according to the standard monitoring of care, which involved the continuous monitoring of electrocardiography, invasive blood pressure, central venous pressure, pulse oximetry, body temperature and hourly urine output. The bispectral index monitor or noninvasive cardiac output monitoring, FloTrac Sensor (EV1000; Edwards Lifesciences Corp, Irvine, CA, USA), was sometimes used. Typically, intravenous induction with propofol and muscle relaxant was performed to facilitate tracheal intubation and a volatile opioid-based technique was used to maintain the anaesthesia. Arterial samples were drawn at regular intervals for the determination of electrolytes, acid-base status and haematocrit.
All surgeries were performed with the patient in the Lloyd-Davies position, as this position allowed easy access to all regions of the abdomen. Intermittent pneumatic calf compressors were used in all patients.
Laparotomy was performed with an extended midline incision. The first phase of the surgery involved dissection, adhesiolysis and determination of the extent of peritoneal involvement by the tumour cells. Peritoneal disease burden was assessed using the peritoneal cancer index (PCI), which scores 13 intra-abdominal sites on a scale of 0 (no disease) to 3 (lesion size > 5 cm), thus giving a range of possible scores from 0 to 39. (5) Involved viscera, which might include the gallbladder, spleen, uterus and ovaries in women and small and/or large bowels, were then resected to remove all macroscopic peritoneal disease, as described by Sugarbaker.
The affected sections of the peritoneum were then stripped. If diaphragmatic stripping was performed, chest drains were inserted before HIPEC to prevent leakage of the chemotherapy drug across the stripped or repaired diaphragm; otherwise, the leakage may exacerbate pleural effusion intraoperatively or in the first few postoperative days. HIPEC was performed after temporary closure of the abdomen. Heated chemotherapy drug, which depended on the tumour origin (mitomycin 10-12.5 mg/m 2 in 1,000 mL of normal saline, cisplatin 50 mg/m 2 in 1,000 mL of normal saline), was infused into the peritoneal cavity for 60-90 minutes. HIPEC works on microscopic disease, targeting lesions < 3 mm. (7) After HIPEC, bowel anastomosis or stoma creation was performed before final abdominal closure.
Normovolaemia was maintained by ensuring appropriate intravenous fluid and blood replacement for insensible fluid and blood losses that may be gradual and may accumulate over the long duration of surgery. In some instances, such as extensive adhesiolysis, blood loss could be extensive. If this occurs in the background of uncorrected hypovolaemia, the patient would develop hypovolaemic shock.
Fluid resuscitation employed the use of crystalloids and colloids, including albumin. In our opinion, the main advantage of colloid over crystalloid is that colloid produces less interstitial oedema. End points such as the maintenance of blood pressure within 20% of the patient's baseline and urine output > 0.5 mL/kg/hour were targeted. As many as 28 (24.8%) patients were extubated immediately after surgery while the remaining 85 (75.2%) patients were admitted to the SICU for ventilator support. The majority of patients admitted to the SICU were extubated on the first (n = 59, 69.4%) and second (n = 11, 12.9%) postoperative days.
Using multivariate analysis, a higher PCI score (17 vs. 7) was the only statistically significant factor for patients who were not extubated immediately after surgery (p < 0.05).
There was a trend towards longer operative time, higher blood loss, and blood and fluid replacements in patients who were not extubated immediately post-operation.
In the immediate postoperative period, 80 (80.0%) patients had elevated prothrombin time (PT) or/and activated prothrombin time (PTT). Patients with postoperative coagulopathy had longer operations, higher PCI scores, greater blood loss, and, greater amounts of blood, frozen plasma, colloid or total fluids administered. However, none of these were statistically significant, except for HIPEC duration (63 minutes vs. 58 minutes; p < 0.05).
For patients who were admitted to the SICU, the median duration before discharge to intermediate care unit or high dependency area was 2 (range 1-28) days. Eight patients required SICU care for more than a week. Patients who stayed longer in the SICU had longer operative times, greater PCI scores, greater blood loss and total fluids administered as well as lower intraoperative base excess, although none of these factors were statistically significant.
The median duration to discharge from hospital was 14 (range 7-188) days. There were 19 patients who required hospitalisation of over 30 days. Patients who required longer hospitalisation (i.e. > 14 days) had higher PCI scores and longer durations of surgery than those who had shorter hospitalisation (603 minutes vs. 498 minutes), with the latter difference being statistically significant. The reasons for prolonged intensive care unit stay or hospitalisation are summarised in Table IV .
DISCUSSION
We presented a series of 111 patients for whom 113 CRS and HIPEC procedures were performed at our institution. Sugarbaker described CRS and HIPEC in 2006, but perioperative outcomes in the literature have not been robust.
(1) To our knowledge, the present study is the largest series that specifically looks at anaesthesia for this combined procedure.
There were several specific perioperative anaesthetic concerns for peritonectomy in our study, which were related to: (a) blood loss and fluid management; (b) analgesia; (c) temperature, airway pressure and acid-base changes; (c) antibiotics; (d) criteria for extubation;
and (e) recovery.
In our patient group, the range of blood loss was wide and corresponded with the extent of surgery. Good communication with the surgical team and vigilance in assessing blood loss and fluid status are thus vital. Blood loss can be sudden and torrential, particularly during the cytoreductive phase and stripping of the liver capsule. Drainage of ascites, blood loss and evaporative losses from raw peritoneal surfaces can deplete intravascular volume dramatically.
Appropriate fluid or blood products should be administered in a timely manner, as guided by clinical estimates of blood loss, urine output, haemodynamics, and haemoglobin and acid-base measurements.
The mean volume of fluids and blood products administered for our patients was large, as a permissive fluid regimen was used to replace blood and fluid losses. However, such a regimen predisposes patients to fluid third-spacing and tissue oedema. The main advantage of using colloids, as compared to crystalloids, was less tissue oedema. Options included hydroxyethyl starch, gelafusine or 5% albumin, which was at the discretion of the anaesthetist.
A restrictive fluid regimen, on the other hand, may expose patients to haemodynamic instability, tissue hypoperfusion, lactic acidosis and exacerbate the renal side effects of chemotherapeutic agents.
There is emerging evidence of the ability of goal-directed therapy in reducing perioperative mortality and morbidity in patients undergoing high-risk surgeries. 
The pulmonary artery catheter (Swan-Ganz CCOmbo; Edwards Life Sciences, Unterschleissheim, Germany) was not used in our series, as its utility did not justify the potential complications. While it provides fascinating physiological data, it has not been shown to alter outcomes. (11) The Flotrac Sensor was used for recent patients in our series and provides a minimally invasive alternative by providing parameters for goal-directed therapy and haemodynamically optimising this high-risk surgery.
Coagulopathy, a recognised complication of CRS and HIPEC, is multifactorial, with massive blood transfusion, dilutional coagulopathy, hypothermia, hypocalcaemia, acidosis or HIPEC being known factors. In our study, we have found suggestions that, in longer and more extensive procedures requiring more colloid or blood replacements, the amount of fresh frozen plasma administered to correct PT or PTT might be insufficient.
Large doses of morphine were required for effective analgesia in our patients due to the despite the large doses of local anaesthetic required in paravertebral blocks, and the incidence of pneumothorax and hypotension is low. (12) Other consequences of HIPEC included changes in body temperature and airway pressure. After anaesthesia induction, the patient's body temperature is allowed to drift towards the lower limit of normal, as body temperature will increase by a mean of 1°C-2°C when HIPEC is performed. In some patients who develop hyperthermia, active cooling measures may be necessary during or after HIPEC. Therefore, the challenge is to maintain normothermia during the cytoreductive phase to minimise the ill effects of hypothermia while avoiding hyperthermia during the HIPEC phase.
Due to the volume of intravenous fluid administration, diaphragmatic peritoneal stripping and/or intraperitoneal chemotherapy, pleural effusion, commonly bilateral, is observed. This and the increase in intra-abdominal pressure during HIPEC explain the mean rise in peak airway pressure in excess of 8 cm H2O. Abdominal filling during HIPEC increases intra-abdominal pressure, which in turn causes cephalad shift of the diaphragm to increase airway pressures and reduce functional residual capacity. These changes, which adversely affect oxygenation and cardiac output, usually do not impact otherwise fit normovolaemic patients clinically. Chest drains inserted prior to the commencement of HIPEC will mitigate the increase in peak airway pressures due to the formation of pleural effusions. Changes in ventilatory parameters are usually not necessary to accommodate the changes in airway pressures.
There is also the need to ensure sufficient antibiotic prophylaxis. In our study, prophylactic antibiotics with a broad-spectrum Gram-negative and anaerobic cover, usually a third-generation cephalosporin (e.g. ceftriaxone and metronidazole), were administered at induction. Redosing of antibiotics at the requisite intervals is important, as the surgery may extend beyond the typical single-dose coverage. Consideration needs to be given for earlier redosing, especially in the face of rapid blood loss and transfusion. Insufficient coverage runs the risk of Gram-negative septicaemia in view of the extensive bowel resection often required, on the background of large exposed and bleeding surface areas. This can have disastrous the consequence of overwhelming sepsis.
There is no standard criterion for extubation, although the duration of surgery, amount of opioids used, blood loss and fluids administered, and patient's body temperature are likely to predict the adequacy of unsupported postoperative ventilation. The final acid-base balance and blood indices will also provide an indication. In the present study, none of these factors were shown to be statistically significant between patients who were extubated immediately post-surgery and those who were not, except PCI score. In this study, PCI score may be a surrogate for the extent of surgery.
In terms of recovery, although the median number of days to discharge was 14 days for our patients, the range (i.e. 7-188 days) was wide. The main reasons that hampered recovery in some patients were repeat procedures or severe postoperative infections. Repeat surgeries were indicated for the treatment of bleeding, anastomosis dehiscence, wound dehiscence and abscess drainage. Interventional radiological procedures were necessary for intra-abdominal abscess drainage or chest drain insertions. Severe nosocomial infections affecting the pulmonary, intra-abdominal or urogenital systems were not uncommon. Few patients required temporary haemodialysis for acute kidney injury as a result of these complications. Despite the eventful recovery seen in some of our patients, all except two survived to recovery and discharge.
Kajdi et al (13) analysed 57 CRS and HIPEC procedures performed at their centre over a Data from Kajdi et al also suggested that the rate of major surgical complications increased significantly with longer operation time and the need for blood transfusion. (13) This was not surprising, as both are surrogates for more extensive operations or intraoperative surgical complications.
Schmidt et al described a retrospective case series of 78 patients who had undergone CRS and HIPEC. (14) Unlike Kajdi et al's and our studies, their median procedure time was shorter at 5 hours 42 minutes and median blood loss lower at 600 mL, suggesting that less extensive surgeries were performed. They found a trend toward earlier extubation in patients who had received epidural analgesia compared to those who received opioid analgesia.
Flaws of retrospective studies are inevitable in our study. We were unable to draw a cause-and-effect relationship between the amount of intraoperative fluid strategy and postoperative outcomes. Due to the small number of patients in our cohort receiving epidural analgesia, we were not able to analyse if its use and its opioid-sparing effect facilitated earlier postoperative extubation, although epidural analgesia's benefits have been shown in other surgeries and the opioid-sparing effects of regional anaesthesia is certainly an outcome of interest. (15) Our experience was drawn over a period of 15 years during which surgical and anaesthesia techniques have improved. It is likely that a patient presenting for CRS and HIPEC today will benefit from our learning curve.
At this juncture, there is insufficient data to conclude the efficacy of specific anaesthetic interventions, such as the use of regional anaesthesia or restrictive fluid management strategy using advanced haemodynamic-monitoring techniques. Until further evidence is available, the use of advanced haemodynamic monitors, such as pulmonary artery catheters or other noninvasive cardiac monitors, will be considered on a case-by-case basis. As the postoperative recovery of these patients may be complicated and eventful, a concerted multidisciplinary effort following a coordinated clinical pathway or protocol may improve outcomes.
In conclusion, as CRS and HIPEC is a major complex surgery with significant morbidity, its perioperative management is a challenge for anaesthetists. Even though many patients who present for this surgery are relatively young and without significant comorbidity, the extensive procedure will result in multisystemic derangements that include the cardiorespiratory system, fluid and acid base balance as well as body temperature. Our study has highlighted some of the perioperative concerns associated with CRS and HIPEC. We look forward to the development of an optimal anaesthetic technique in conjunction with evidencebased medicine.
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